Minerva Surgical Inc (UTRS)
0.001
0.00 (0.00%)
USD |
OTCM |
May 07, 16:00
Minerva Surgical Cash from Operations (TTM): -38.73M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -38.73M |
| June 30, 2023 | -40.44M |
| March 31, 2023 | -36.33M |
| December 31, 2022 | -35.57M |
| Date | Value |
|---|---|
| September 30, 2022 | -31.00M |
| June 30, 2022 | -29.31M |
| March 31, 2022 | -27.08M |
| December 31, 2021 | -22.38M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-40.44M
Minimum
Jun 2023
-22.38M
Maximum
Dec 2021
-32.60M
Average
-33.28M
Median
Cash from Operations (TTM) Benchmarks
| Viveve Medical Inc | -16.23M |
| HTG Molecular Diagnostics Inc | -16.83M |
| Stereotaxis Inc | -9.139M |
| Electromed Inc | 4.872M |
| Myomo Inc | -6.173M |